Dr. David Israeli is the Chairman & CEO of Magenta Medical, a start-up company developing innovative therapies for the treatment of acute decompensated heart failure. Immediately prior to this, David was the Chief Medical Officer of Ossio Ltd., a start-company developing novel implants for orthopedic fixation.
Previously, he was a life sciences General Partner at Pitango Venture Capital, one of the leading VC groups in Israel, where he led investments in the areas of medical devices and digital health.
Before joining Pitango, David was the Director of Business Development and Marketing at Medtronic Ventor Technologies, following Medtronic’s acquisition of Ventor Technologies in early 2009.
Prior to this, David spent several years in the United States. After earning an MBA, he joined Medtronic and filled roles ranging from corporate development and M&A to business and market development. David then went on to become the VP of Medical Affairs at Rhythmia Medical, which was acquired by Boston Scientific in October 2012. David holds an MD from the Hebrew University of Jerusalem and an MBA from the Harvard Business School.
David Israeli
